This Article Full Text Full Text (PDF) All Versions of this Article: 200802-282OCv1 178/5/527    most recent Alert me when this article is cited Alert me if a correction is posted Services Related articles in AJRCCM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eurich, D. T. Articles by Majumdar, S. R. Search for Related Content PubMed PubMed Citation Articles by Eurich, D. T. Articles by Majumdar, S. R.

Mortality Reduction with Influenza Vaccine in Patients with Pneumonia Outside "Flu" Season

Pleiotropic Benefits or Residual Confounding?

¹ Department of Public Health Sciences, School of Public Health, and the ² Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada

Correspondence and requests for reprints should be addressed to Dean T. Eurich, Ph.D., Assistant Professor, School of Public Health, University of Alberta, 13-103 Clinical Sciences Bldg., Edmonton, AB, T6G 2G3 Canada. E-mail: deurich{at}ualberta.ca

Rationale: Observational studies suggest a 50% mortality reduction for older patients receiving influenza vaccination; some deem this magnitude of benefit implausible and invoke confounding by the "healthy user effect" as an alternate explanation.

Objectives: To evaluate unrecognized confounding by hypothesizing the presence of a 50% mortality reduction with vaccination for patients with pneumonia outside of influenza season.

Methods: Clinical, laboratory, and functional data were prospectively collected on 1,813 adults with community-acquired pneumonia admitted to six hospitals outside of influenza season in the Capital Health region (AB, Canada). Vaccination status was ascertained by interview and chart review. Outcome was in-hospital mortality. Influenza-vaccinated patients were matched to a nonvaccinated control using propensity scores, and then multivariable regression was used to determine the independent association between vaccination and mortality.

Measurements and Main Results: The cohort consisted of 352 vaccine recipients and 352 matched control subjects. Most (85%) patients were 65 years or older, 29% had severe pneumonia, and 12% died. Influenza vaccination was associated with a 51% mortality reduction (28 of 352 [8%] died vs. 53 of 352 [15%] control subjects; unadjusted odds ratio [OR], 0.49; 95% confidence interval [CI], 0.30–0.79; P = 0.004) outside influenza season. Adjustment for age, sex, and comorbidities did not alter these findings (adjusted OR, 0.45; 95% CI, 0.27–0.76). More complete adjustment for confounding (e.g., functional and socioeconomic status) markedly attenuated these benefits and their statistical significance (adjusted OR, 0.81; 95% CI, 0.35–1.85; P = 0.61).

Conclusions: The 51% reduction in mortality with vaccination initially observed in patients with pneumonia who did not have influenza was most likely a result of confounding. Previous observational studies may have overestimated mortality benefits of influenza vaccination.

Key Words: influenza • bias • prospective study • pneumonia

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Observational studies report a 50% reduction in mortality associated with influenza vaccination; however, many scientists contend that this magnitude of benefit is implausible. What This Study Adds to the Field The results of this study suggest that many previous observational studies have overestimated the mortality benefits of influenza vaccination due to difficult-to-correct confounding attributable to the "healthy-user" effect.

 

Related articles in AJRCCM:

Benefits of Examining Influenza Vaccine Associations Outside of Influenza Season

Lisa A. Jackson
AJRCCM 2008 178: 439-440. [Full Text]  

This article has been cited by other articles:

				C. McCabe, C. Kirchner, H. Zhang, J. Daley, and D. N. Fisman Guideline-Concordant Therapy and Reduced Mortality and Length of Stay in Adults With Community-Acquired Pneumonia: Playing by the Rules Arch Intern Med, September 14, 2009; 169(16): 1525 - 1531. [Abstract] [Full Text] [PDF]

				S. B. Mossad Influenza in long-term care facilities: Preventable, detectable, treatable Cleveland Clinic Journal of Medicine, September 1, 2009; 76(9): 513 - 521. [Abstract] [Full Text] [PDF]

				R. H. H. Groenwold, A. W. Hoes, and E. Hak Impact of influenza vaccination on mortality risk among the elderly Eur. Respir. J., July 1, 2009; 34(1): 56 - 62. [Abstract] [Full Text] [PDF]

				R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld Update in Critical Care 2008 Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 743 - 758. [Full Text] [PDF]

				T Jefferson, C Di Pietrantonj, M G Debalini, A Rivetti, and V Demicheli Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review BMJ, February 12, 2009; 338(feb12_2): b354 - b354. [Abstract] [Full Text] [PDF]

				R. F. Grossman Community-Acquired Pneumonia: Advances in Management ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 359 - 368. [Full Text] [PDF]

				S. B. MOSSAD 2008-2009 Influenza update: A better vaccine match Cleveland Clinic Journal of Medicine, December 1, 2008; 75(12): 865 - 870. [Abstract] [Full Text] [PDF]

				R. E Jordan and J. I Hawker Influenza vaccine in the over 65s BMJ, November 18, 2008; 337(nov18_3): a2545 - a2545. [Full Text]

				L. A. Jackson Benefits of Examining Influenza Vaccine Associations Outside of Influenza Season Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 439 - 440. [Full Text] [PDF]